Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity.
Abstract
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.
Abstract
Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 Model.
Abstract
The relevance of non-human primate and rodent malaria models for humans.
Abstract